+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Neurointerventional Balloon Dilatation Catheter Market by Product Type (Compliant, Non Compliant, Semi Compliant), Balloon Shape (Standard, Steerable, Tapered), Guidewire Compatibility, Application, End User, Coating Technology - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6147827
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Revealing the advanced material, design, and regulatory forces driving the evolution of neurointerventional balloon dilatation catheters

The evolution of neurointerventional balloon dilatation catheters reflects profound advances in minimally invasive therapies for vascular pathologies of the brain and surrounding vasculature. As clinicians strive for enhanced deliverability, precision, and patient safety, the technological fabric of these catheters has been rewoven to offer unprecedented flexibility, trackability, and controlled inflation dynamics. Modern balloon dilatation platforms integrate innovations in material science, such as novel polymers and hybrid composites, to ensure conformity to complex intracranial and extracranial anatomies while maintaining controlled radial force profiles.

Amid this transformative landscape, the catheter’s design philosophy has shifted from mere luminal dilation to active lesion remodeling with integrated coatings and compatibility with next-generation guidewire systems. Regulatory bodies worldwide are emphasizing rigorous safety protocols, driving iterative refinements in balloon compliance, catheter shaft architecture, and hydrophilic surface treatments. This alignment of clinician needs, patient safety imperatives, and regulatory stringency underpins the rising prominence of neurointerventional balloon dilatation catheters as cornerstones of vascular therapy strategies.

Exploring the convergence of imaging, personalized medicine, and hybrid procedural suites reshaping neurointerventional treatment paradigms

In recent years, the neurointerventional arena has encountered seismic shifts driven by burgeoning demand for minimally invasive solutions and an aging global population prone to cerebrovascular incidents. The integration of digital imaging, such as high-resolution three-dimensional rotational angiography, has revolutionized pre-procedural planning and real-time navigation, enabling precise deployment of balloon catheters within tortuous vasculature. Simultaneously, the rise of hybrid operating rooms equipped with advanced imaging suites has blurred the lines between diagnostic and therapeutic interventions, thereby accelerating procedural throughput and expanding clinical capabilities.

Concurrently, a growing emphasis on personalized medicine has steered R&D investments toward customizable catheter profiles that can be tailored to each patient’s anatomical and pathological characteristics. The confluence of artificial intelligence algorithms for image analysis and digital twin simulations has unlocked predictive models that guide balloon sizing and optimize inflation parameters. Together, these transformative shifts underscore a pivotal era in which technology convergence is fundamentally reshaping clinical pathways and elevating the standard of care for neurovascular interventions.

Analyzing the complex interplay between 2025 US tariffs, supply chain realignment, and value-based purchasing pressures

The implementation of updated United States tariffs in 2025 has injected nuanced complexity into the cost structure and supply chain dynamics of the neurointerventional balloon dilatation catheter market. Import duties on advanced polymers and specialty alloys have elevated production expenses for manufacturers with sourcing strategies reliant on cross-border procurement. This shift has prompted multinational firms to reevaluate supplier bases and pursue strategic nearshoring initiatives to mitigate exposure to tariff volatility and logistical bottlenecks.

Moreover, Medicare reimbursement adjustments and evolving healthcare policies have influenced hospital procurement budgets, increasing scrutiny on total cost of ownership for disposable catheter platforms. Payer entities are demanding value-based evidence of clinical outcomes, compelling suppliers to demonstrate not only product efficacy and safety but also downstream economic benefits, such as reduced procedure times and shorter hospital stays. Collectively, the 2025 tariff landscape is fostering heightened collaboration between manufacturers, healthcare providers, and policymakers to align cost containment imperatives with sustained clinical innovation.

Unpacking the layered segmentation framework spanning compliance, shape, guidewire compatibility, application, end user, and coating technology

The neurointerventional balloon dilatation catheter market exhibits multifaceted segmentation that illuminates diverse product profiles and clinical applications. By product type, the market is examined across compliant, non compliant, and semi compliant balloon architectures, each further differentiated by their suitability for extracranial and intracranial procedures. This granularity reveals adoption patterns where compliant balloons dominate peripheral and carotid applications while non compliant variants are preferred for precise aneurysm neck remodeling, and semi compliant designs bridge nuanced intracranial challenges.

Beyond product compliance, balloon shape emerges as a critical parameter, encompassing standard profiles for straightforward stenotic lesions, steerable configurations for navigating tortuous vessels, and tapered options tailored for lesions with variable lumen diameters. Guidewire compatibility segmentation distinguishes catheters designed for 0.014 inch platforms, 0.018 inch platforms, and 0.035 inch platforms, underscoring the interplay between catheter flexibility and guidewire stiffness requirements. Furthermore, application segmentation bifurcates into extracranial and intracranial domains, with extracranial procedures focusing on carotid artery and peripheral artery dilatation, and intracranial interventions addressing aneurysm and vasospasm management. End user segmentation captures utilization patterns across ambulatory surgical centers, hospitals, and specialty clinics, reflecting the settings in which these devices deliver clinical value. Finally, coating technology segmentation differentiates between drug-coated surfaces that offer prophylactic anti-restenotic therapy and plain balloons optimized for mechanical dilation, highlighting therapeutic and procedural priorities.

Revealing the distinct innovation drivers and adoption barriers across the Americas, EMEA, and Asia-Pacific territories

Regional insights into the neurointerventional balloon dilatation catheter market reveal dynamic trends and distinct strategic imperatives across geographies. In the Americas, robust reimbursement frameworks and a high prevalence of trained neurointerventionalists accelerate adoption of advanced compliant and steerable balloon platforms. The region’s emphasis on bundled payment models is also driving suppliers to demonstrate clear value propositions through efficiency gains and improved patient outcomes.

Across Europe, the Middle East and Africa, heterogeneous regulatory landscapes and variable healthcare infrastructure create a patchwork of opportunity and challenge. High-income European nations lead in intracranial aneurysm management protocols and favor drug-coated technology, whereas emerging economies in the Middle East and Africa are prioritizing cost-effective non compliant models to address rising incidence of peripheral vascular disease. Collaborative consortia and public-private partnerships are instrumental in elevating procedural standards and expanding access in underserved markets.

In the Asia-Pacific region, rapid urbanization and rising healthcare expenditure are catalyzing demand for neurointerventional solutions. Japan and Australia represent mature markets with established tenders for steerable and semi compliant catheters, while China and India are witnessing accelerated adoption driven by large patient populations, increasing training programs for specialists, and government initiatives to bolster stroke care networks. These regional disparities emphasize the need for tailored market entry strategies and differentiated value communication.

Mapping the competitive arena where global medtech giants and specialized innovators vie through collaboration and digital integration

The competitive landscape of the neurointerventional balloon dilatation catheter market is characterized by a mix of global medtech leaders and agile specialized firms. Key players leverage integrated R&D pipelines to expand product portfolios that encompass compliant, non compliant, and semi compliant balloons, while also exploring advanced coating chemistries for anti-restenotic efficacy. Strategic alliances, licensing agreements, and targeted acquisitions are common tactics to secure intellectual property, enhance manufacturing capabilities, and broaden geographic reach.

Innovation is further fueled by cross-sector partnerships that integrate digital health platforms with catheter design, enabling real-time data capture on inflation pressures and procedural workflows. Leading companies are piloting connectivity solutions that feed procedural metrics into cloud-based analytics, empowering hospitals to benchmark performance and optimize resource allocation. As new entrants introduce specialized steerable and tapered catheters, incumbents are reinforcing their market positions by strengthening post-market surveillance, expanding training programs for interventionalists, and securing key contracts with tier-one healthcare systems.

Outlining strategic priorities to align product agility, data integration, supply chain resilience, and clinician training for market leadership

Industry leaders can capitalize on market momentum by prioritizing strategic actions that align with evolving clinical and economic imperatives. First, investing in modular catheter platforms that can be rapidly customized for intracranial or extracranial indications will heighten agility amid shifting reimbursement policies. Second, forging partnerships with digital imaging and analytics firms can enrich procedural data streams, supporting value-based contracting and post-market evidence generation.

Furthermore, to mitigate tariff-related cost pressures, supply chain diversification through regional manufacturing hubs and nearshoring agreements can enhance resilience and shorten lead times. In parallel, companies should accelerate development of drug-coated balloon technologies that address restenosis, positioning these products as premium solutions with demonstrable patient benefits. Lastly, scalable training initiatives and remote proctoring frameworks will disseminate best practices and bolster adoption among emerging neurointerventionalists, unlocking new markets while safeguarding procedural outcomes.

Detailing the combined primary and secondary research approach with expert validation and multi-source data triangulation

This research leverages a robust methodology combining primary interviews with leading neurointerventionalists, hospital procurement officers, and device manufacturers, along with secondary sources such as regulatory filings, clinical trial registries, and peer-reviewed journals. Data triangulation ensures consistency by cross-validating clinical adoption rates, procedural volumes, and reimbursement trends across multiple geographies.

Market modeling employs bottom-up analyses informed by hospital procedure databases and distributor shipment records, while qualitative insights are drawn from advisory board discussions and expert panel workshops. Technological assessments of catheter materials, coatings, and design innovations are conducted through patent landscape reviews and product specification audits. All findings undergo rigorous peer review by an independent steering committee of vascular neurologists and interventional radiologists to uphold analytical integrity and relevance.

Synthesizing the interplay of innovation, regulation, segmentation, and regional dynamics into a cohesive market blueprint

The neurointerventional balloon dilatation catheter market stands at the intersection of rapid technological innovation, shifting regulatory frameworks, and evolving clinical protocols. Advanced materials and digital integration are driving device differentiation, while regional tariff policies and value-based reimbursement models are reshaping cost structures and purchasing behaviors. Segmentation analysis underscores the diverse needs of compliant, non compliant, and semi compliant catheter users across extracranial and intracranial applications, guiding portfolio strategies.

Regional insights highlight tailored market entry imperatives across the Americas, EMEA, and Asia-Pacific, whereas competitive intelligence reveals a landscape defined by collaboration, digital health partnerships, and strategic acquisitions. Actionable recommendations point toward modular design platforms, enhanced data analytics integration, supply chain agility, and clinician training as critical levers for sustainable growth. Together, these findings coalesce into a comprehensive blueprint for stakeholders looking to navigate market complexities and capture new opportunities in neurovascular therapy.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Compliant
      • Extracranial
      • Intracranial
    • Non Compliant
      • Extracranial
      • Intracranial
    • Semi Compliant
      • Extracranial
      • Intracranial
  • Balloon Shape
    • Standard
    • Steerable
    • Tapered
  • Guidewire Compatibility
    • 0.014 Inch
    • 0.018 Inch
    • 0.035 Inch
  • Application
    • Extracranial
      • Carotid Artery
      • Peripheral Artery
    • Intracranial
      • Aneurysm
      • Vasospasm
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialty Clinics
  • Coating Technology
    • Drug Coated
    • Plain
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Medtronic plc
  • Stryker Corporation
  • Boston Scientific Corporation
  • Terumo Corporation
  • Penumbra, Inc.
  • MicroPort Scientific Corporation
  • Asahi Intecc Co., Ltd.
  • Abbott Laboratories
  • Cardinal Health, Inc.
  • Johnson & Johnson

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of advanced balloon materials with drug-eluting properties for improved vessel patency and reduced restenosis
5.2. Development of low-profile neurointerventional dilatation catheters for improved navigation in tortuous intracranial vessels
5.3. Adoption of dual-lumen catheter designs combining balloon dilatation and aspiration functionality for efficient stroke intervention
5.4. Emergence of biodegradable balloon coatings to minimize inflammatory response and reduce need for follow-up interventions
5.5. Increasing use of high-resolution imaging compatibility in balloon dilatation systems to enhance procedural precision and safety
5.6. Focus on developing hydrophilic coating technologies to improve catheter trackability in complex cerebrovascular anatomies
5.7. Collaboration between device manufacturers and AI software developers to enable real-time lesion assessment during balloon angioplasty procedures
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Neurointerventional Balloon Dilatation Catheter Market, by Product Type
8.1. Introduction
8.2. Compliant
8.2.1. Extracranial
8.2.2. Intracranial
8.3. Non Compliant
8.3.1. Extracranial
8.3.2. Intracranial
8.4. Semi Compliant
8.4.1. Extracranial
8.4.2. Intracranial
9. Neurointerventional Balloon Dilatation Catheter Market, by Balloon Shape
9.1. Introduction
9.2. Standard
9.3. Steerable
9.4. Tapered
10. Neurointerventional Balloon Dilatation Catheter Market, by Guidewire Compatibility
10.1. Introduction
10.2. 0.014 Inch
10.3. 0.018 Inch
10.4. 0.035 Inch
11. Neurointerventional Balloon Dilatation Catheter Market, by Application
11.1. Introduction
11.2. Extracranial
11.2.1. Carotid Artery
11.2.2. Peripheral Artery
11.3. Intracranial
11.3.1. Aneurysm
11.3.2. Vasospasm
12. Neurointerventional Balloon Dilatation Catheter Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Hospitals
12.4. Specialty Clinics
13. Neurointerventional Balloon Dilatation Catheter Market, by Coating Technology
13.1. Introduction
13.2. Drug Coated
13.3. Plain
14. Americas Neurointerventional Balloon Dilatation Catheter Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Neurointerventional Balloon Dilatation Catheter Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Neurointerventional Balloon Dilatation Catheter Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Medtronic plc
17.3.2. Stryker Corporation
17.3.3. Boston Scientific Corporation
17.3.4. Terumo Corporation
17.3.5. Penumbra, Inc.
17.3.6. MicroPort Scientific Corporation
17.3.7. Asahi Intecc Co., Ltd.
17.3.8. Abbott Laboratories
17.3.9. Cardinal Health, Inc.
17.3.10. Johnson & Johnson
18. Research AI19. Research Statistics20. Research Contacts21. Research Articles22. Appendix
List of Figures
FIGURE 1. NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY BALLOON SHAPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY BALLOON SHAPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY GUIDEWIRE COMPATIBILITY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY GUIDEWIRE COMPATIBILITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COATING TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COATING TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET: RESEARCHAI
FIGURE 28. NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET: RESEARCHSTATISTICS
FIGURE 29. NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET: RESEARCHCONTACTS
FIGURE 30. NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COMPLIANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COMPLIANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COMPLIANT, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COMPLIANT, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY NON COMPLIANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY NON COMPLIANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY NON COMPLIANT, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY NON COMPLIANT, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SEMI COMPLIANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SEMI COMPLIANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SEMI COMPLIANT, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SEMI COMPLIANT, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY BALLOON SHAPE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY BALLOON SHAPE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY STANDARD, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY STANDARD, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY STEERABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY STEERABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY TAPERED, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY TAPERED, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY GUIDEWIRE COMPATIBILITY, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY GUIDEWIRE COMPATIBILITY, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY 0.014 INCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY 0.014 INCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY 0.018 INCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY 0.018 INCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY 0.035 INCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY 0.035 INCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY CAROTID ARTERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY CAROTID ARTERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PERIPHERAL ARTERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PERIPHERAL ARTERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY ANEURYSM, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY ANEURYSM, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY VASOSPASM, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY VASOSPASM, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COATING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COATING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY DRUG COATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY DRUG COATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PLAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PLAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COMPLIANT, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COMPLIANT, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY NON COMPLIANT, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY NON COMPLIANT, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SEMI COMPLIANT, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SEMI COMPLIANT, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY BALLOON SHAPE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY BALLOON SHAPE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY GUIDEWIRE COMPATIBILITY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY GUIDEWIRE COMPATIBILITY, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COATING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COATING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COMPLIANT, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COMPLIANT, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY NON COMPLIANT, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY NON COMPLIANT, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SEMI COMPLIANT, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SEMI COMPLIANT, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY BALLOON SHAPE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY BALLOON SHAPE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY GUIDEWIRE COMPATIBILITY, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY GUIDEWIRE COMPATIBILITY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COATING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COATING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 131. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COMPLIANT, 2018-2024 (USD MILLION)
TABLE 134. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COMPLIANT, 2025-2030 (USD MILLION)
TABLE 135. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY NON COMPLIANT, 2018-2024 (USD MILLION)
TABLE 136. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY NON COMPLIANT, 2025-2030 (USD MILLION)
TABLE 137. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SEMI COMPLIANT, 2018-2024 (USD MILLION)
TABLE 138. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SEMI COMPLIANT, 2025-2030 (USD MILLION)
TABLE 139. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY BALLOON SHAPE, 2018-2024 (USD MILLION)
TABLE 140. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY BALLOON SHAPE, 2025-2030 (USD MILLION)
TABLE 141. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY GUIDEWIRE COMPATIBILITY, 2018-2024 (USD MILLION)
TABLE 142. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY GUIDEWIRE COMPATIBILITY, 2025-2030 (USD MILLION)
TABLE 143. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, 2018-2024 (USD MILLION)
TABLE 146. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, 2025-2030 (USD MILLION)
TABLE 147. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, 2018-2024 (USD MILLION)
TABLE 148. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, 2025-2030 (USD MILLION)
TABLE 149. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COATING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. CANADA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COATING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COMPLIANT, 2018-2024 (USD MILLION)
TABLE 156. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COMPLIANT, 2025-2030 (USD MILLION)
TABLE 157. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY NON COMPLIANT, 2018-2024 (USD MILLION)
TABLE 158. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY NON COMPLIANT, 2025-2030 (USD MILLION)
TABLE 159. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SEMI COMPLIANT, 2018-2024 (USD MILLION)
TABLE 160. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SEMI COMPLIANT, 2025-2030 (USD MILLION)
TABLE 161. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY BALLOON SHAPE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY BALLOON SHAPE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY GUIDEWIRE COMPATIBILITY, 2018-2024 (USD MILLION)
TABLE 164. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY GUIDEWIRE COMPATIBILITY, 2025-2030 (USD MILLION)
TABLE 165. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, 2018-2024 (USD MILLION)
TABLE 168. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, 2025-2030 (USD MILLION)
TABLE 169. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, 2018-2024 (USD MILLION)
TABLE 170. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, 2025-2030 (USD MILLION)
TABLE 171. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COATING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. MEXICO NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COATING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COMPLIANT, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COMPLIANT, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY NON COMPLIANT, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY NON COMPLIANT, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SEMI COMPLIANT, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SEMI COMPLIANT, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY BALLOON SHAPE, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY BALLOON SHAPE, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY GUIDEWIRE COMPATIBILITY, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY GUIDEWIRE COMPATIBILITY, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COATING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COATING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COMPLIANT, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COMPLIANT, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY NON COMPLIANT, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY NON COMPLIANT, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SEMI COMPLIANT, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SEMI COMPLIANT, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY BALLOON SHAPE, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY BALLOON SHAPE, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY GUIDEWIRE COMPATIBILITY, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY GUIDEWIRE COMPATIBILITY, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COATING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COATING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COMPLIANT, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COMPLIANT, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY NON COMPLIANT, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY NON COMPLIANT, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SEMI COMPLIANT, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SEMI COMPLIANT, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY BALLOON SHAPE, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY BALLOON SHAPE, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY GUIDEWIRE COMPATIBILITY, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY GUIDEWIRE COMPATIBILITY, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COATING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COATING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COMPLIANT, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY COMPLIANT, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY NON COMPLIANT, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY NON COMPLIANT, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SEMI COMPLIANT, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY SEMI COMPLIANT, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY BALLOON SHAPE, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY BALLOON SHAPE, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY GUIDEWIRE COMPATIBILITY, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY GUIDEWIRE COMPATIBILITY, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY EXTRACRANIAL, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY INTRACRANIAL, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM NEUROINTERVENTIONAL BALLOON DILATATION CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MIL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Neurointerventional Balloon Dilatation Catheter Market report include:
  • Medtronic plc
  • Stryker Corporation
  • Boston Scientific Corporation
  • Terumo Corporation
  • Penumbra, Inc.
  • MicroPort Scientific Corporation
  • Asahi Intecc Co., Ltd.
  • Abbott Laboratories
  • Cardinal Health, Inc.
  • Johnson & Johnson